ARCHIMED Acquires Irrimax Corporation

ARCHIMED Acquires Groupe Laboratoire Rivadis

September 8, 2025

Consumer Products

ARCHIMED, a healthcare-focused private equity firm, has acquired Groupe Laboratoire Rivadis, a French developer and manufacturer of dermo-cosmetics and hygiene products (brands include Rivadouce, Milton and Auriège). The seller, majority shareholder Christian Lainé, is reinvesting a meaningful portion of proceeds; ARCHIMED plans to support Rivadis' growth and strengthen its position in the consumer health / dermo-cosmetics market.

ARCHIMED Acquires WiQo S.p.A.

March 9, 2023

Medical Devices

ARCHIMED, a Europe-based healthcare private equity firm, has acquired WiQo, an Italian developer and manufacturer of the PRX‑T33 topical biostimulator used in aesthetic medicine. Founders (Dr. Rossana Castellana and family) retained a 25% stake and Castellana will stay on to lead R&D; the deal was financed with debt provided by Banco BPM and Crédit Agricole Italia and is the fourth investment from ARCHIMED's MED III fund.

ARCHIMED Acquires BioVendor Group

March 11, 2025

Medical Devices

ARCHIMED, a Europe-focused private equity firm specializing in healthcare, has acquired BioVendor Group, a Brno-headquartered developer and manufacturer of in‑vitro diagnostics and immunoassays. ARCHIMED will partner with existing management to accelerate internationalization, product innovation and commercial expansion as part of its MED III fund's diagnostics investment strategy.

ARCHIMED Acquires Majority Stake in Cardioline

November 17, 2021

Medical Devices

Trans-Atlantic private equity firm ARCHIMED has acquired a majority stake in Cardioline, a Trento, Italy-based maker of cardiology devices and Europe's largest provider of cardiology-focused telemedicine. The investment, made through ARCHIMED's MED III Fund, will support Cardioline's product and software development, international expansion and potential add-on M&A while founders retain a significant minority stake and remain in management.

ARCHIMED Acquires Majority Stake in Cube (Cube Biotech)

November 3, 2021

Biotechnology

Transatlantic healthcare private equity firm ARCHIMED has purchased a majority stake in Monheim, Germany-based Cube (Cube Biotech), a specialist provider of high-purity, stable membrane proteins for drug discovery. ARCHIMED will support Cube's US market expansion and broaden its product and service offering organically and via acquisitions while Cube's founding management remain significant shareholders and continue to lead the business.

ARCHIMED (via MED Platform I) Acquires Majority Stake in SUANFARMA

November 18, 2021

Pharmaceuticals

Transatlantic healthcare-focused private equity firm ARCHIMED, through its MED Platform I (MPI) fund, has acquired a majority stake in Madrid-based SUANFARMA, a manufacturer and distributor of active pharmaceutical ingredients (APIs) and nutraceutical ingredients. Ares Management provided debt financing for the transaction; SUANFARMA founder Héctor Ara and members of management rolled a material minority stake into the business and remain significant shareholders.